Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04736667 · ClinicalTrials.gov registry record
Mitral Valve Screening Survey
A clinical trial of Mitral Valve Disease, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 16
- Study locations
NCT04736667: Recruiting study of Mitral Valve Disease, sponsored by Medstar Health Research Institute.
NCT04736667 is a study of Mitral Valve Disease that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 1,000 participants, above the 256-participant average among 5 other Mitral Valve Disease trials with a reported enrollment target (291% higher). The trial reports 16 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04736667, a study of Mitral Valve Disease, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).
Conditions Studied
Study Locations (16)
Florida
- Morton Plant Hospital - Clearwater
- HealthPark Medical Center - Fort Myers
Arizona
- Phoenix Cardiovascular Research Group - Phoenix
California
- Keck Hospital of USC - Los Angeles
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Illinois
- Northwestern University - Chicago
Iowa
- MercyOne Iowa Heart Center - West Des Moines
Kansas
- University of Kansas Medical Center - Kansas City
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2027-02 |
What NCT04736667 shows while recruiting
NCT04736667 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 256-participant average among 5 other Mitral Valve Disease trials with a reported enrollment target (291% higher).
The record links to 1 condition, with Mitral Valve Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04736667 lists 16 locations in 15 states (Florida, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT04736667 about?
NCT04736667 is a clinical study titled "Mitral Valve Screening Survey". This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).
What is the current status of trial NCT04736667?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2021-08-06. Estimated completion is 2027-02.
What conditions does trial NCT04736667 study?
This clinical trial studies the following conditions: Mitral Valve Disease.
Who is sponsoring clinical trial NCT04736667?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04736667 being conducted?
This trial has 16 study locations across Arizona, California, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
RECRUITING · NA
-
Abbott Cephea Mitral Valve Disease Registry
RECRUITING
-
A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation
ACTIVE NOT RECRUITING · NA
-
PARTNER 3 Trial - Mitral Valve in Valve
ACTIVE NOT RECRUITING · NA
-
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI